469 related articles for article (PubMed ID: 36982601)
1. Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases.
Britzen-Laurent N; Weidinger C; Stürzl M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982601
[TBL] [Abstract][Full Text] [Related]
2. The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.
Brazil JC; Louis NA; Parkos CA
Inflamm Bowel Dis; 2013 Jun; 19(7):1556-65. PubMed ID: 23598816
[TBL] [Abstract][Full Text] [Related]
3. Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease.
Hatoum OA; Binion DG; Gutterman DD
Eur J Clin Invest; 2005 Oct; 35(10):599-609. PubMed ID: 16178878
[TBL] [Abstract][Full Text] [Related]
4. Intestinal barrier dysfunction in inflammatory bowel diseases.
McGuckin MA; Eri R; Simms LA; Florin TH; Radford-Smith G
Inflamm Bowel Dis; 2009 Jan; 15(1):100-13. PubMed ID: 18623167
[TBL] [Abstract][Full Text] [Related]
5. Role of sphingosine-1-phosphate receptors in vascular injury of inflammatory bowel disease.
Wang X; Chen S; Xiang H; Liang Z; Lu H
J Cell Mol Med; 2021 Mar; 25(6):2740-2749. PubMed ID: 33595873
[TBL] [Abstract][Full Text] [Related]
6. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
7. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
[TBL] [Abstract][Full Text] [Related]
8. Layered defense: how mucus and tight junctions seal the intestinal barrier.
Capaldo CT; Powell DN; Kalman D
J Mol Med (Berl); 2017 Sep; 95(9):927-934. PubMed ID: 28707083
[TBL] [Abstract][Full Text] [Related]
9. miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel Disease.
Xiao X; Mao X; Chen D; Yu B; He J; Yan H; Wang J
Front Immunol; 2022; 13():868229. PubMed ID: 35493445
[TBL] [Abstract][Full Text] [Related]
10. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.
Michielan A; D'Incà R
Mediators Inflamm; 2015; 2015():628157. PubMed ID: 26582965
[TBL] [Abstract][Full Text] [Related]
12. The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases: focus on inflammatory bowel diseases.
Dohi T; Burkly LC
J Leukoc Biol; 2012 Aug; 92(2):265-79. PubMed ID: 22672874
[TBL] [Abstract][Full Text] [Related]
13. Pathway-based approaches to the treatment of inflammatory bowel disease.
Bamias G; Pizarro TT; Cominelli F
Transl Res; 2016 Jan; 167(1):104-15. PubMed ID: 26408803
[TBL] [Abstract][Full Text] [Related]
14. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.
Deban L; Correale C; Vetrano S; Malesci A; Danese S
Am J Pathol; 2008 Jun; 172(6):1457-66. PubMed ID: 18458096
[TBL] [Abstract][Full Text] [Related]
15. Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease.
Binion DG; West GA; Ina K; Ziats NP; Emancipator SN; Fiocchi C
Gastroenterology; 1997 Jun; 112(6):1895-907. PubMed ID: 9178682
[TBL] [Abstract][Full Text] [Related]
16. A defect in epithelial barrier integrity is not required for a systemic response to bacterial antigens or intestinal injury in T cell receptor-alpha gene-deficient mice.
Sydora BC; Tavernini MM; Doyle J; Fedorak RN
Inflamm Bowel Dis; 2006 Aug; 12(8):750-7. PubMed ID: 16917231
[TBL] [Abstract][Full Text] [Related]
17. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
Peng K; Xia S; Xiao S; Yu Q
J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
[TBL] [Abstract][Full Text] [Related]
18. Influence and Implications of the Molecular Paradigm of Nitric Oxide Underlying Inflammatory Reactions of the Gastrointestinal Tract of Dog: A Major Hallmark of Inflammatory Bowel Disease.
Rana T
Inflamm Bowel Dis; 2022 Aug; 28(8):1280-1288. PubMed ID: 35312776
[TBL] [Abstract][Full Text] [Related]
19. Role of eosinophils in inflammatory bowel and gastrointestinal diseases.
Woodruff SA; Masterson JC; Fillon S; Robinson ZD; Furuta GT
J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):650-61. PubMed ID: 21593640
[TBL] [Abstract][Full Text] [Related]
20. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
Satokari R
Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
